The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Enzyme induction with antiepileptic drugs: Cause for concern?
Abstract
Summary: Several commonly prescribed antiepileptic drugs (AEDs)—including phenobarbital, phenytoin, and carbamazepine—stimulate the synthesis of a broad range of monooxygenase and conjugating enzymes. These agents are well known to reduce the duration and action of many lipid‐ and non–lipid‐soluble drugs, including anticoagulants, cytotoxics, analgesics, antiretrovirals, glucocorticoids, statins, antihypertensives, oral contraceptives, psychoactive drugs, immunosuppressants, and of course, other AEDs. This process, therefore, may be associated with a number of clinical problems including higher cancer mortality, progressive AIDS, transplant rejection, and unwanted pregnancy. Withdrawal of enzyme‐inducing AEDs will increase the concentration of induced drugs, bringing with it substantial risk of toxicity if doses are not concomitantly reduced. Yet the potential widespread adverse health consequences of these interactions, both with AED initiation and withdrawal, remain largely underappreciated. Furthermore, induction also affects enzymes involved in endogenous metabolic pathways, and can alter bone biochemistry, gonadal steroids, and lipid markers. Therefore, enzyme‐inducing AEDs may contribute to the development of a number of comorbidities, including osteoporosis, sexual dysfunction, and vascular disease. This process continues as long as the patient takes the inducer. Modern AEDs that do not possess this property have similar efficacy for the common epilepsies. Accordingly, perhaps consideration should be given to starting treatment with, or even switching patients to, non–enzyme‐inducing AEDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature
Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199602000-00002 · Cited by 2,945
Priority actions for the non-communicable disease crisis
Beaglehole, R., Bonita, R., Horton, R., Adams, C., Alleyne, G., Asaria, P., Baugh, V., Bekedam, H., Billo, N., Casswell, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60393-0 · Cited by 1,615
Clinical importance of the cytochromes P450
Nebert, D. W., & Russell, D. W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11203-7 · Cited by 1,414
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
Vredenburgh, J. J., Desjardins, A., Herndon, J. E., Marcello, J., Reardon, D. A., Quinn, J. A., Rich, J. N., Sathornsumetee, S., Gururangan, S., Sampson, J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2440 · Cited by 1,394
Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., Cramp, C., Cockerell, O. C., Cooper, P. N., Doughty, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60460-7 · Cited by 976
Patterns of treatment response in newly diagnosed epilepsy
Brodie, M. J., Barry, S. J. E., Bamagous, G. A., Norrie, J. D., & Kwan, P. (2012) · Neurology · doi:10.1212/wnl.0b013e3182563b19 · Cited by 931
Self-citationGlauser, T., Ben‐Menachem, E., Bourgeois, B., Cnaan, A., Chadwick, D., Guerreiro, C., Kalviainen, R., Mattson, R., Perucca, E., & Tomson, T. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00585.x · Cited by 790
French, J. A., Kanner, A. M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C. L., Theodore, W. H., Bazil, C., Stern, J., Schachter, S. C., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000123693.82339.fc · Cited by 654
Self-citationThe Epidemiology of the Comorbidity of Epilepsy in the General Population
Gaitatzis, A., Carroll, K., Majeed, A., & Sander, J. W. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.17504.x · Cited by 603
Inhibition and induction of human cytochrome P450 enzymes: current status
Pelkonen, O., Turpeinen, M., Hakkola, J., Honkakoski, P., Hukkanen, J., & Raunio, H. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0332-8 · Cited by 569
UDP-glucuronosyltransferases and clinical drug-drug interactions
KIANG, T., ENSOM, M., & CHANG, T. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.013 · Cited by 552
Homocysteine and folate as risk factors for dementia and Alzheimer disease
Ravaglia, G., Forti, P., Maioli, F., Martelli, M., Servadei, L., Brunetti, N., Porcellini, E., & Licastro, F. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.636 · Cited by 500
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy
Brodie, M. J., Perucca, E., Ryvlin, P., Ben-Menachem, E., & Meencke, H.-J. (2007) · Neurology · doi:10.1212/01.wnl.0000252941.50833.4a · Cited by 467
Self-citationHomocysteine and stroke: evidence on a causal link from mendelian randomisation
Casas, J. P., Bautista, L. E., Smeeth, L. L., Sharma, P. K., & Hingorani, A. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17742-3 · Cited by 444
Kerr, M. P., Mensah, S., Besag, F., de Toffol, B., Ettinger, A., Kanemoto, K., Kanner, A., Kemp, S., Krishnamoorthy, E., LaFrance Jr, W. C., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03276.x · Cited by 425
Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study
Sillanpää, M., & Schmidt, D. (2006) · Brain · doi:10.1093/brain/awh726 · Cited by 414
Self-citationDrugs as P-glycoprotein substrates, inhibitors, and inducers
Kim, R. B. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001389 · Cited by 382
Substrates of human hepatic cytochrome P450 3A4
Li, A. (1995) · Toxicology · doi:10.1016/0300-483x(95)03155-9 · Cited by 367
Effect of antiepileptic drugs on bone density in ambulatory patients
Farhat, G., Yamout, B., Mikati, M. A., Demirjian, S., Sawaya, R., & El-Hajj Fuleihan, G. (2002) · Neurology · doi:10.1212/wnl.58.9.1348 · Cited by 358
Randomised study of antiepileptic drug withdrawal in patients in remission
MEDICALRESEARCHCOUNCILANTIEPILE (1991) · The Lancet · doi:10.1016/0140-6736(91)92856-w · Cited by 354
The pharmacological treatment of epilepsy in adults
Perucca, E., & Tomson, T. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70047-3 · Cited by 334
Nilsson, L., Tomson, T., Farahmand, B. Y., Diwan, V., & Persson, P. G. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01194.x · Cited by 331
Clinically Significant Pharmacokinetic Drug Interactions with Carbamazepine: An Update
Spina, E., Pisani, F., & Perucca, E. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631030-00004 · Cited by 331
Potential Drug Interactions and Duplicate Prescriptions Among Cancer Patients
Riechelmann, R. P., Tannock, I. F., Wang, L., Saad, E. D., Taback, N. A., & Krzyzanowska, M. K. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk130 · Cited by 328
Possible involvement of pregnane X receptor–enhanced CYP24 expression in drug-induced osteomalacia
Pascussi, J., Robert, A., Nguyen, T. M., Walrant-Debray, O., Garabédian, M., Martin, P. G. P., Pineau, T., Saric, J., Navarro, F., Maurel, P., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200521867 · Cited by 317
Phenobarbital-Induced Alterations in Vitamin D Metabolism
Hahn, T. J., Birge, S. J., Scharp, C. R., & Avioli, L. V. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106868 · Cited by 309
Antiepileptic drug therapy the story so far
Brodie, M. J. (2010) · Seizure · doi:10.1016/j.seizure.2010.10.027 · Cited by 298
Self-citationPascussi, J.-M., Gerbal-Chaloin, S., Duret, C., Daujat-Chavanieu, M., Vilarem, M.-J., & Maurel, P. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105349 · Cited by 298
Effect of carbamazepine and valproate on bone mineral density
Sheth, R. D., Wesolowski, C. A., Jacob, J. C., Penney, S., Hobbs, G. R., Riggs, J. E., & Bodensteiner, J. B. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70304-7 · Cited by 293
Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects
di Masi, A., Marinis, E. D., Ascenzi, P., & Marino, M. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.04.002 · Cited by 288
Liu, D., & Dillon, J. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200491200 · Cited by 285
Interactions between antiepileptic and chemotherapeutic drugs
Vecht, C. J., Wagner, G. L., & Wilms, E. B. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00435-6 · Cited by 256
Self-citationZhou, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27793 · Cited by 256
The long-term risk of premature mortality in people with epilepsy
Neligan, A., Bell, G. S., Johnson, A. L., Goodridge, D. M., Shorvon, S. D., & Sander, J. W. (2011) · Brain · doi:10.1093/brain/awq378 · Cited by 255
Mechanisms of cytochrome P450 induction
Tompkins, L. M., & Wallace, A. D. (2007) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20180 · Cited by 251
Fracture Risk Associated with Use of Antiepileptic Drugs
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.18804.x · Cited by 241
Effect of epilepsy and antiepileptic drugs on male reproductive health
Isojärvi, J. I. T., Löfgren, E., Juntunen, K. S. T., Pakarinen, A. J., Päivänsalo, M., Rautakorpi, I., & Tuomivaara, L. (2004) · Neurology · doi:10.1212/01.wnl.0000098936.46730.64 · Cited by 237
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma
Reardon, D. A., Desjardins, A., Vredenburgh, J. J., Gururangan, S., Friedman, A. H., Herndon, J. E., Marcello, J., Norfleet, J. A., McLendon, R. E., Sampson, J. H., et al. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9950-0 · Cited by 232
McIlroy, S. P., Dynan, K. B., Lawson, J. T., Patterson, C. C., & Passmore, A. P. (2002) · Stroke · doi:10.1161/01.str.0000032550.90046.38 · Cited by 227
A Structural Basis for Constitutive Activity in the Human CAR/RXRα Heterodimer
Xu, R. X., Lambert, M. H., Wisely, B. B., Warren, E. N., Weinert, E. E., Waitt, G. M., Williams, J. D., Collins, J. L., Moore, L. B., Willson, T. M., et al. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.042 · Cited by 226
Effects of antiepileptic drugs on lipids, homocysteine, and C‐reactive protein
Mintzer, S., Skidmore, C. T., Abidin, C. J., Morales, M. C., Chervoneva, I., Capuzzi, D. M., & Sperling, M. R. (2009) · Annals of Neurology · doi:10.1002/ana.21615 · Cited by 221
Self-citationPrados, M. D., Lamborn, K. R., Chang, S., Burton, E., Butowski, N., Malec, M., Kapadia, A., Rabbitt, J., Page, M. S., Fedoroff, A., et al. (2006) · Neuro-Oncology · doi:10.1215/s1522851705000451 · Cited by 218
Effects of long‐term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis
Chuang, Y., Chuang, H., Lin, T., Chang, C., Lu, C., Chang, W., Chen, S., Tan, T., Huang, C., & Chan, S. H. H. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2011.03316.x · Cited by 217
Use of antiepileptic drugs and risk of fractures: Case–control study among patients with epilepsy
Souverein, P. C., Webb, D. J., Weil, J. G., Van Staa, T. P., & Egberts, A. C. G. (2006) · Neurology · doi:10.1212/01.wnl.0000210503.89488.88 · Cited by 214
HepaRG Cells as an in Vitro Model for Evaluation of Cytochrome P450 Induction in Humans
Kanebratt, K. P., & Andersson, T. B. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017418 · Cited by 214
Rosenfeld, W. E., Doose, D. R., Walker, S. A., & Nayak, R. K. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01123.x · Cited by 210
Souverein, P. C., Webb, D. J., Petri, H., Weil, J., Van Staa, T. P., & Egberts, T. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.23804.x · Cited by 207
Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy
Pack, A. M., Morrell, M. J., Marcus, R., Holloway, L., Flaster, E., Doñe, S., Randall, A., Seale, C., & Shane, E. (2005) · Annals of Neurology · doi:10.1002/ana.20378 · Cited by 206
Self-citationAntiepileptic Drug–Induced Bone Loss in Young Male Patients Who Have Seizures
Andress, D. L. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.781 · Cited by 205
Phase 1 Trial of Gefitinib Plus Sirolimus in Adults with Recurrent Malignant Glioma
Reardon, D. A., Quinn, J. A., Vredenburgh, J. J., Gururangan, S., Friedman, A. H., Desjardins, A., Sathornsumetee, S., Herndon, J. E., Dowell, J. M., McLendon, R. E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2215 · Cited by 191
Interactions Between Antiepileptic Drugs and Hormonal Contraception
Crawford, P. (2002) · CNS Drugs · doi:10.2165/00023210-200216040-00005 · Cited by 189
Oberndorfer, S., Piribauer, M., Marosi, C., Lahrmann, H., Hitzenberger, P., & Grisold, W. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-2338-2 · Cited by 183
Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia
Relling, M. V., Pui, C.-H., Sandlund, J. T., Rivera, G. K., Hancock, M. L., Boyett, J. M., Schuetz, E. G., & Evans, W. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02503-4 · Cited by 183
The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids.
Crawford, P., Chadwick, D., Martin, C., Tjia, J., Back, D., & Orme, M. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb05457.x · Cited by 179
Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy
Herzog, A. G., Drislane, F. W., Schomer, D. L., Pennell, P. B., Bromfield, E. B., Dworetzky, B. A., Farina, E. L., & Frye, C. A. (2005) · Neurology · doi:10.1212/01.wnl.0000178988.78039.40 · Cited by 173
Chang, S. M., Kuhn, J. G., Rizzo, J., Robins, H. I., Schold, S. C., Spence, A. M., Berger, M. S., Mehta, M. P., Bozik, M. E., Pollack, I., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2188 · Cited by 166
Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy
Pack, A. M., Morrell, M. J., Randall, A., McMahon, D. J., & Shane, E. (2008) · Neurology · doi:10.1212/01.wnl.0000310981.44676.de · Cited by 165
Self-citationIncreased Bone Turnover in Prepubertal, Pubertal, and Postpubertal Patients Receiving Carbamazepine
Verrotti, A., Greco, R., Latini, G., Morgese, G., & Chiarelli, F. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.13002.x · Cited by 162
Heart Disease Mortality and Morbidity in Patients with Epilepsy
Annegers, J. F., Hauser, W. A., & Shirts, S. B. (1984) · Epilepsia · doi:10.1111/j.1528-1157.1984.tb03480.x · Cited by 160
Bone density and antiepileptic drugs: a case-controlled study
Stephen, L. J., McLellan, A. R., Harrison, J. H., Shapiro, D., Dominiczak, M. H., Sills, G. J., & Brodie, M. J. (1999) · Seizure · doi:10.1053/seiz.1999.0301 · Cited by 159
Self-citationAntiepileptic drugs interact with folate and vitamin B12 serum levels
Linnebank, M., Moskau, S., Semmler, A., Widman, G., Stoffel‐Wagner, B., Weller, M., & Elger, C. E. (2011) · Annals of Neurology · doi:10.1002/ana.22229 · Cited by 159
Reitman, M. L., Chu, X., Cai, X., Yabut, J. A., Venkatasubramanian, R., Zajic, S. C., Stone, J. A., Ding, Y., Witter, R., Gibson, C. R., et al. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.271 · Cited by 159
Bone health in people with epilepsy: Is it impaired and what are the risk factors?
Pack, A. M. (2008) · Seizure · doi:10.1016/j.seizure.2007.11.020 · Cited by 156
Self-citationDepression in epilepsy: a critical review from a clinical perspective
Hoppe, C., & Elger, C. E. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.104 · Cited by 154
Cloughesy, T. F., Wen, P. Y., Robins, H. I., Chang, S. M., Groves, M. D., Fink, K., Junck, L., Schiff, D., Abrey, L. E., Gilbert, M. R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2323 · Cited by 154
Lim, D. A., Tarapore, P. E., Chang, E. F., Burt, M., Chakalian, L., Barbaro, N. M., Chang, S. M., Lamborn, K. R., & McDermott, M. W. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9781-4 · Cited by 144
Clinical Significance of Pharmacokinetic Interactions Between Antiepileptic and Psychotropic Drugs
Spina, E., & Perucca, E. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.043s2037.x · Cited by 143
(1998) · PubMed · Cited by 141
Olesen, J. B., Abildstrom, S. Z., Erdal, J., Gislason, G., Weeke, P. E., Andersson, C., Torp-Pedersen, C. T., & Hansen, P. R. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2186 · Cited by 140
Long‐term antiepileptic drug therapy contributes to the acceleration of atherosclerosis
Tan, T., Lu, C., Chuang, H., Lin, T., Liou, C., Chang, W., & Chuang, Y. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02024.x · Cited by 137
Bock, K. W. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.034 · Cited by 137
Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine
Verrotti, A., Pascarella, R., Trotta, D., Giuva, T., Morgese, G., & Chiarelli, F. (2000) · Epilepsy Research · doi:10.1016/s0920-1211(00)00150-9 · Cited by 135
Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics
Hassan, M., �berg, G., Bj�rkholm, M., et al. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686213 · Cited by 135
A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy
Kim, S. H., Lee, J. W., Choi, K., et al. (2007) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.11.007 · Cited by 135
Hamed, S. A., Hamed, E. A., Hamdy, R., & Nabeshima, T. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2007.03.010 · Cited by 129
Potential Drug Interactions in Cancer Patients Receiving Supportive Care Exclusively
Riechelmann, R. P., Zimmermann, C., Chin, S. N., Wang, L. E., O'Carroll, A., Zarinehbaf, S., & Krzyzanowska, M. K. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.06.009 · Cited by 125
The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy
Back, D. J., Bates, M., Bowden, A., Breckenridge, A., Hall, M. J., Jones, H. L., MacIver, M., Orme, M., Perucca, E., Richens, A., et al. (1980) · Contraception · doi:10.1016/0010-7824(80)90102-x · Cited by 125
Ghosh, C., Gonzalez-Martinez, J. A., Hossain, M. K., Cucullo, L., Fazio, V. J., Janigro, D., & Marchi, N. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02428.x · Cited by 124
Predictors of bone density in ambulatory patients on antiepileptic drugs
Fuleihan, G. E., Dib, L. H., Yamout, B., Sawaya, R. A., & Mikati, M. A. (2008) · Bone · doi:10.1016/j.bone.2008.03.002 · Cited by 124
Premature mortality in people with epilepsy in rural China: a prospective study
Ding, D., Wang, W., Wu, J., Ma, G., Dai, X., Yang, B., Wang, T., Yuan, C., Hong, Z., de Boer, H. M., et al. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70528-2 · Cited by 117
Carbamazepine, Phenytoin, Sex Hormones, and Sexual Function in Men with Epilepsy
Isojärvi, J. I. T., Repo, M., Pakarinen, A., Lukkarinen, O. A., & Myllylä, V. V. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01011.x · Cited by 115
Antiepileptic Drugs and Markers of Vascular Risk
LoPinto‐Khoury, C., & Mintzer, S. (2010) · Current Treatment Options in Neurology · doi:10.1007/s11940-010-0080-y · Cited by 115
Self-citationLucas, R. A., Gilfillan, D. J., & Bergstrom, R. F. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050527 · Cited by 114
Effect of antiepileptic medication on bone mineral measures
Petty, S., Paton, L. M., O'Brien, T. J., Makovey, J., Erbas, B., Sambrook, P. N., Berkovic, S. F., & Wark, J. D. (2005) · Neurology · doi:10.1212/01.wnl.0000180910.72487.18 · Cited by 108
Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid
Uçar, M., Neuvonen, M., Luurila, H., Dahlqvist, R., Neuvonen, P. J., & Mj�rndal, T. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0700-5 · Cited by 107
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs
Belcastro, V., Striano, P., Gorgone, G., Costa, C., Ciampa, C., Caccamo, D., Pisani, L. R., Oteri, G., Marciani, M. G., Aguglia, U., et al. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02303.x · Cited by 107
Carbone, L. D., Johnson, K., Robbins, J. A., Larson, J. C., Curb, J. D., Watson, K. C., Gass, M. L. S., & LaCroix, A. Z. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091027 · Cited by 106
Villikka, K., Kivistö, K. T., MAENPAA, H., JOENSUU, H., & Neuvonen, P. J. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)90067-x · Cited by 105
Assessment of potential drug interactions in patients with epilepsy: Impact of age and sex
Gidal, B. E., French, J. A., Grossman, P., & Teuff, G. L. (2009) · Neurology · doi:10.1212/01.wnl.0000341789.77291.8d · Cited by 98
Self-citationLiver Enzyme Induction and Serum Lipid Levels After Replacement of Carbamazepine with Oxcarbazepine
Isojärvi, J. I. T., Pakarinen, A., Rautio, A., Pelkonen, O., & Myllylä, V. V. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb01792.x · Cited by 98
Interactions between Antiepileptic and Antipsychotic Drugs
Besag, F., & Berry, D. (2006) · Drug Safety · doi:10.2165/00002018-200629020-00001 · Cited by 96
Serum Lipid Levels During Carbamazepine Medication
Isojärvi, J. I. T. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540060030012 · Cited by 94
Antiepileptic Drug Therapy and Sexual Function in Men with Epilepsy
Duncan, S., Blacklaw, J., Beastall, G. H., & Brodie, M. J. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb02075.x · Cited by 93
Self-citationLossius, M. I., Taubøll, E., Mowinckel, P., Mørkrid, L., & Gjerstad, L. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01147.x · Cited by 92
Nikolaos, T., Stylianos, G., Nikolaou, C., Irini, P., Christos, M., Dimitrios, T., Konstantinos, P., & Antonis, T. (2004) · PubMed · Cited by 92
Magnusson, M. O., Dahl, M.-L., Cederberg, J., Karlsson, M., & Sandström, R. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100431 · Cited by 90
Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma
Jaeckle, K. A., Ballman, K. V., Furth, A. F., & Buckner, J. C. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bbfeca · Cited by 89
Morrell, M. J., Flynn, K. L., Doñe, S., Flaster, E. R., Kalayjian, L. A., & Pack, A. M. (2005) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.01.004 · Cited by 88
Self-citationOlesen, J. B., Hansen, P. R., Abildstrom, S. Z., Andersson, C., Weeke, P. E., Schmiegelow, M., Erdal, J., Torp-Pedersen, C. T., & Gislason, G. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2073 · Cited by 88
Causes of death among people with convulsive epilepsy in rural West China
Mu, J., Liu, L., Zhang, Q., Si, Y., Hu, J., Fang, J., Gao, Y., He, J., Li, S., Wang, W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318223c784 · Cited by 87
Røste, L. S., Taubøll, E., Haugen, T. B., Bjørnenak, T., Sætre, E., & Gjerstad, L. (2003) · European Journal of Neurology · doi:10.1046/j.1468-1331.2003.00615.x · Cited by 84
Galimberti, C. A., Magri, F., Copello, F., Arbasino, C., Cravello, L., Casu, M., Patrone, V., & Murialdo, G. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.59704.x · Cited by 83
Nallani, S. C., Glauser, T. A., Hariparsad, N., Setchell, K. D. R., Buckley, D. J., Buckley, A. R., & Desai, P. B. (2003) · Epilepsia · doi:10.1111/j.0013-9580.2003.06203.x · Cited by 83
Kuhn, J. G., Chang, S. M., Wen, P. Y., Cloughesy, T. F., Greenberg, H. S., Schiff, D., Conrad, C. A., Fink, K., Robins, H. I., Mehta, M. P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0781 · Cited by 83
Should enzyme‐inducing antiepileptic drugs be considered first‐line agents?
Mintzer, S., & Mattson, R. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02235.x · Cited by 79
Self-citationMuuronen, A., Kaste, M., Nikkilä, E., & Tolppanen, E. ‐. (1985) · BMJ · doi:10.1136/bmj.291.6507.1481 · Cited by 79
Davis, A. R., Westhoff, C. L., & Stanczyk, F. Z. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02917.x · Cited by 75
Isojärvi, J. I. T. (1990) · Epilepsia · doi:10.1111/j.1528-1157.1990.tb05500.x · Cited by 75
Pursche, S., Schleyer, E., Bonin, M. V., Ehninger, G., Said, S. M., Prondzinsky, R., Illmer, T., Wang, Y., Hosius, C., Nikolova, Z. G., et al. (2008) · Current Clinical Pharmacology · doi:10.2174/157488408785747656 · Cited by 75
Effect of Phenobarbitone Treatment on Vitamin D Metabolism in Mammals
Silver, J., Neale, G., & Thompson, G. R. (1974) · Clinical Science · doi:10.1042/cs0460433 · Cited by 68
Unplanned pregnancy in an epileptic.
Kenyon, I. E. (1972) · BMJ · doi:10.1136/bmj.1.5801.686-c · Cited by 67
Exposure to antiepileptic drugs and the risk of hip fracture: A case‐control study
Tsiropoulos, I., Andersen, M. T., Nymark, T., Lauritsen, J. L., Gaist, D., & Hallas, J. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01640.x · Cited by 65
Dana-Haeri, J., Oxley, J. R., & Richens, A. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb00071.x · Cited by 64
Fleishaker, J. C., Pearson, L. K., & Peters, G. R. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840305 · Cited by 64
Cloughesy, T. F., Kuhn, J. G., Robins, H. I., Abrey, L. E., Wen, P. Y., Fink, K., Lieberman, F. S., Mehta, M. P., Chang, S. M., Yung, A. W. K., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.068 · Cited by 64
The role of cytochrome P450 in the regulation of cholesterol biosynthesis
Gibbons, G. F. (2002) · Lipids · doi:10.1007/s11745-002-1016-x · Cited by 63
Stjernholm, M. R., & Katz, F. H. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-41-5-887 · Cited by 63
The recovery time‐course of CYP3A after induction by St John's wort administration
Imai, H., Kotegawa, T., Tsutsumi, K., Morimoto, T., Eshima, N., Nakano, S., & Ohashi, K. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03120.x · Cited by 61
Elevated plasma concentrations of lipoprotein(a) in medicated epileptic patients
Schwaninger, M., Ringleb, P. A., Annecke, A., Winter, R., Kohl, B., Werle, E., Fiehn, W., Rieser, P. A., & Walter‐Sack, I. (2000) · Journal of Neurology · doi:10.1007/s004150070111 · Cited by 61
Lombardo, L., Pellitteri, R., Balazy, M., & Cardile, V. (2008) · Current Neurovascular Research · doi:10.2174/156720208784310196 · Cited by 61
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme
Puduvalli, V. K., Giglio, P., Groves, M. D., Hess, K. R., Gilbert, M. R., Mahankali, S., Jackson, E. F., Levin, V. A., Conrad, C. A., Hsu, S. H., et al. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-060 · Cited by 60
Interaction of Dexamethasone with Phenytoin
Lackner, T. E. (1991) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1991.tb04300.x · Cited by 58
Raizer, J. J., Abrey, L. E., Lassman, A. B., Chang, S., Lamborn, K. R., Kuhn, J. G., Yung, W. K. A., Gilbert, M. R., Aldape, K., Wen, P. Y., et al. (2009) · Neuro-Oncology · doi:10.1093/neuonc/nop017 · Cited by 56
Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model
Botts, S. R., Díaz, F. J., Santoro, V., Spina, E., Muscatello, M. R. A., Cogollo, M. R., Castro, F. E., & de León, J. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.04.018 · Cited by 55
Reproductive Dysfunction in Women With Epilepsy: Antiepileptic Drug Effects on Sex-Steroid Hormones
Morrell, M. J., Flynn, K. L., Seale, C. G., Doñe, S., Paulson, A. J., Flaster, E. R., & Ferin, M. (2001) · CNS Spectrums · doi:10.1017/s1092852900001528 · Cited by 55
Tomson, T., Svensson, J. O., & Hilton-Brown, P. (1989) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198909000-00008 · Cited by 50
Hormonal and reproductive disturbances in epileptic male patients: Emerging issues
Verrotti, A., Loiacono, G., Laus, M., Coppola, G., Chiarelli, F., & Tiboni, G. M. (2011) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.02.002 · Cited by 49
Mula, M. (2008) · Current Drug Metabolism · doi:10.2174/138920008786049311 · Cited by 47
Mintzer, S., Skidmore, C. T., Rankin, S. J., Chervoneva, I., Pequinot, E., Capuzzi, D. M., & Sperling, M. R. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.10.001 · Cited by 38
Self-citationAmbroziak, K., Kuteykin‐Teplyakov, K. B., Luna‐Tortós, C., Alfalah, M., Fedrowitz, M., & Löscher, W. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.11.051 · Cited by 37
Differential Effects of Antiepileptic Drugs on Neuroactive Steroids in Men with Epilepsy
Herzog, A. G., Drislane, F. W., Schomer, D. L., Pennell, P. B., Bromfield, E. B., Dworetzky, B. A., Farina, E. L., & Frye, C. A. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00826.x · Cited by 37
homme, R. L. F. A. L., Dijkema, T., van der Ven, A. J. A. M., & Burger, D. M. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000234089.41785.c8 · Cited by 36
Zhu, B. T. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903578642 · Cited by 34
Characterization of the Time Course of Carbamazepine Deinduction by an Enzyme Turnover Model
Punyawudho, B., Cloyd, J. C., Leppik, I. E., Ramsay, R. E., Marino, S. E., Pennell, P. B., White, J. R., & Birnbaum, A. K. (2009) · Clinical Pharmacokinetics · doi:10.2165/00003088-200948050-00003 · Cited by 33
Clinical consequences of microsomal enzyme-induction by antiepileptic drugs
Perucca, E. (1978) · Pharmacology & Therapeutics Part C Clinical Pharmacology and Therapeutics · doi:10.1016/s0362-5486(78)80004-1 · Cited by 31
Lipid Profile, Apolipoproteins A and B in Children With Epilepsy
Tomoum, H. Y., Awadallah, M., Fouad, D. A., & Ali, A. H. (2008) · Journal of Child Neurology · doi:10.1177/0883073808318538 · Cited by 25
Candrilli, S. D., Manjunath, R., Davis, K. L., & Gidal, B. E. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.07.021 · Cited by 23
Self-citationCyclosporine-phenytoin interaction.
D’Souza, M. J., Pollock, S. H., & Solomon, H. M. (1988) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06925-9 · Cited by 21
Frey, B. M., & Frey, F. J. (1984) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1984.tb00695.x · Cited by 21
Galimberti, C. A., Magri, F., Copello, F., Arbasino, C., Chytiris, S., Casu, M., Ameri, P., Perucca, P., & Murialdo, G. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01966.x · Cited by 21
Wada, K., Takada, M., Ueda, T., et al. (2007) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp45524 · Cited by 17
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Cited by
Thijs, R. D., Surges, R., O'Brien, T. J., & Sander, J. W. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32596-0 · Cited by 2,183
The consequences of refractory epilepsy and its treatment
Laxer, K. D., Trinka, E., Hirsch, L. J., Cendes, F., Langfitt, J., Delanty, N., Resnick, T., & Benbadis, S. R. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.05.031 · Cited by 679
New avenues for anti-epileptic drug discovery and development
Löscher, W., Klitgaard, H., Twyman, R. E., & Schmidt, D. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4126 · Cited by 675
Self-citationDrug treatment of epilepsy in adults
Schmidt, D., & Schachter, S. C. (2014) · BMJ · doi:10.1136/bmj.g254 · Cited by 323
Self-citationInteractions between antiepileptic drugs, and between antiepileptic drugs and other drugs
Zaccara, G., & Perucca, E. (2014) · Epileptic Disorders · doi:10.1684/epd.2014.0714 · Cited by 305
Metadata
- Authors
- Brodie, M. J., Mintzer, S., Pack, A. M., Gidal, B. E., Vecht, C. J., & Schmidt, D.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2012-09-27
- Volume
- 54
- Issue
- 1
- Pages
- 11-27
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W1565364436
- Cited by
- 383
- References
- 143
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.